Advertisement

Topics

ILEX Oncology Company Profile

10:29 EDT 18th October 2018 | BioPortfolio

Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product candidates. The pipeline comprises multiple technologies at all stages of clinical development, including a monoclonal antibody, apoptosis-inducing agents, cytotoxic compounds with novel mechanisms of action, angiogenesis inhibitors and chemoprevention agents.

Location

11550 IH 10 West
San Antonio
TX
78230
United States of America


News Articles [455 Associated News Articles listed on BioPortfolio]

Ilex Medical Ltd ILX Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryIlex Medical Ltd Ilex is a medical device company that markets disposables and reagents, and diagnostic equipment. The company provides in vitro diagnostic equipment, laboratory management soft...

Ockham Oncology’s CSO highlights global strength of fully integrated company.

Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Ne...

Analysis of oncology pipeline

Oncology research, which includes the medical, radiation, and surgical fields, is always ongoing. Therefore, the oncology pipeline is a key...Read More... The post Analysis of oncology pipeline appear...

Axel Hoos, GSK: Focusing on immuno-oncology and cancer epigenetics

GSK has had a recent change in Oncology after recently divesting their marketed oncology products to Novartis whilst retaining their R&D pipeline. During BIO 2015, Axel Hoos, VP Oncology R&D at GSK ex...

ASCO endorses the integration of quackery into breast cancer care

In 2014, the Society for Integrative Oncology first published clinical guidelines for the care of breast cancer patients. Not surprisingly, SIO advocated "integrating" dubious therapies with oncology....

bluebird bio and Gritstone Oncology to Collaborate

bluebird bio (NASDAQ:BLUE) and Gritstone Oncology announced Thursday (August 23) in a joint press release the two will research, develop and commercialize oncology cell therapy treatments. The post bl...

Immuno-Oncology Conference 2018

26 - 27 September, London, UK. Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference will focus on a few key...

Shire announces sale of oncology business to Servier for $2.4 billion

Oncology business provides Servier with an immediate presence in the US, enhancing its commitment to addressing unmet patient needs in oncology

PubMed Articles [1247 Associated PubMed Articles listed on BioPortfolio]

The therapeutic effect of Ilex pubescens extract on blood stasis model rats according to serum metabolomics.

Ilex pubescens Hook. et Arn (MDQ), a traditional Chinese herb, is used in the treatment of cardiovascular diseases. However, the mechanisms underlying the preventive effect of MDQ on blood stasis rema...

Ilex asprella aqueous extracts exert in vivo anti-inflammatory effects by regulating the NF-κB, JAK2/STAT3, and MAPK signaling pathways.

Ilex asprella (Hook. et Arn.) Champ. ex Benth. (IA) is a representative medicinal plant from the South of the Five Ridges of China. Its roots (RIA) and stems (SIA) have been traditionally used for the...

A pair of new diastereoisomeric phenylpropanoid-substituted flavan from the leaves of Ilex centrochinensis.

A pair of new diastereoisomeric flavan, containing an additional phenylpropanoid (C-C) unit in the molecule, has been isolated from the leaves of Ilex centrochinensis. Their structures were identified...

Simultaneous qualitative and quantitative evaluation of Ilex kudingcha C. J. tseng by using UPLC and UHPLC-qTOF-MS/MS.

In this study, a systematic method was established for the holistic quality control of Ilex kudingcha C. J. Tseng, a popular functional drink for adjuvant treatment of diabetes, hypertension, obesity ...

New triterpenoid saponins from the leaves of Ilex chinensis.

Eight new triterpenoid saponins, including four ursane-type saponins, ilexchinenosides J-M (1-4), and four oleanane-type saponins, ilexchinenosides N-Q (5-8), along with three known triterpenoid sapon...

Clinical Trials [537 Associated Clinical Trials listed on BioPortfolio]

Yerba Mate (Ilex Paraguariensis A.St.-Hil.): Assessment of Cardiovascular Health

Mate or yerba-mate (Ilex paraguariensis A.St.-Hil.) is a native plant from South America highly consumed in this region. Different traditional products (mate, mate tea, chimarrao, tereré)...

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Companies [736 Associated Companies listed on BioPortfolio]

ILEX Oncology

Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product...

ILEX Oncology Incorporated

ILEX Oncology, Inc. is a drug development company focused exclusively on accelerated development of drugs for thetreatment and prevention of cancer. The Company uses its expertise in the identificatio...

Tessman Technology Limited

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Test-Mall

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Boston Millennia Partners

Boston Millennia Partners is a private equity investment partnership managing over $700 million in capital. Millennia invests in high-growth businesses in the healthcare and busin...

More Information about "ILEX Oncology" on BioPortfolio

We have published hundreds of ILEX Oncology news stories on BioPortfolio along with dozens of ILEX Oncology Clinical Trials and PubMed Articles about ILEX Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ILEX Oncology Companies in our database. You can also find out about relevant ILEX Oncology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record